Overview
February 2-4: Forum
The last few years have shed light on the importance of operational efficiency of the management of regulatory information to ensure quality regulatory submission to health authorities. We have seen how the ability to perform at this level has allowed drug companies to bring therapeutics and vaccines to patients faster. At DIA’s Regulatory Submissions, Information, and Document Management (RSIDM) Forum, we will hear from industry and regulatory stakeholders working across the scope of regulatory information to examine current and evolving data standards and requirements and effective regulatory information management approaches to align related people, processes, and technology. Our Forum brings a set of tracks and focus areas, equipping our attendees with invaluable insights on how to build and sustain successful RSIDM foundations, optimize their current processes and procedures, adopt innovative technologies, and achieve regulatory excellence. This Forum provides multiple opportunities for networking, knowledge sharing, and education for both business and technology-focused attendees at all levels.
While we develop our 2026 Agenda, please take a moment to review our 2025 FINAL PROGRAM!
Participant Testimonials
The forum was incredibly valuable in terms of meeting colleagues from around the world —industry and regulators — and collaborating on solutions to improve submission efficiency andmake data more readily usable. – Virginia Hussong, Chief Data Standards Program, CBDER, FDA
Fantastic forum! I am 17 years in the pharmaceutical industry, but new to the regulatory sector, and it was great to align my prior manufacturing knowledge to the regulatory area. Great event! All the right people, all in the right place! – Matthew Tyler, Director of Business Development, Qdossier, a Celegence Company
The breadth of subject matter expertise, and diverse perspectives make RSIDM a must attend event for anyone involved in Regulatory activities. – Gary Colantonio, MS, MBA, Associate Director, Regulatory Affairs, Merck & Co., Inc.
Featured
Want to learn more about Regulatory Submissions, Information, and Document Management Forum? You've come to the right site!
Program Committee
-
Jillian E. Carinci, MS Senior Director, Head of Submission Sciences
Biogen, United States -
Maria Sagoua, MHA Director of Regulatory Innovation
Accumulus Technologies, United States -
Jared Lantzy, PMP Executive Director, Global Regulatory Operations
Novavax, Inc., United States -
Noelia Plaza Director of Process Excellence & Analytics
Daiichi Sankyo, United States -
Jonathan Resnick, PMP Project Management Officer, OBI, OSP, CDER
FDA, United States -
Rita Algorri, PhD, MS Associate Director, Global Regulatory Affairs (CMC)
Amgen, United States -
Venkatraman Balasubramanian, PhD, MBA Healthcare and Life Sciences Strategic Advisor
VB Insights, LLC, United States -
Rachel Bombara Sr. Regulatory Services Manager
Certara, United States
Have an account?